NCT05178979

Brief Summary

Gender norms embedded in the health-system and broader community shape patient-provider relationships in ways that may undermine the provision of antiretroviral treatment (ART) counseling for men and women in Uganda. This study seeks to develop and evaluate the acceptability, feasibility, and preliminary efficacy of an innovative gender transformative implementation strategy to improve HIV provider capacity for equitable HIV care and ART adherence counseling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
382

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

December 31, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 5, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

April 25, 2025

Completed
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

2.1 years

First QC Date

November 15, 2021

Results QC Date

January 27, 2025

Last Update Submit

April 8, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Proportion of Missed Antiretroviral (ARV) Doses From Baseline Among Clients

    AACTG Adherence Instruments, self-reported questionnaire on medication adherence from the Adult AIDS Clinical Trials Group (AACTG); operationalized as a proportion of total missed doses (missed doses/total doses) (continuous measure, range =0.0-1.0)

    Baseline, 6-months, and 12-months

  • Change in Clinic Visit Adherence From Baseline Among Patients (Retention in Care)

    Proportion of kept visits/scheduled visits (kept + missed visits) (continuous measure, range =0.0-1.0)

    Baseline, 6-months, and 12-months

  • Change in Competence for Gender-sensitive Care From Baseline Among Providers

    Adapted from the Nijmegen Gender Awareness in Medicine Scale (N-GAMS); collected from provider cohort; 9 items, total possible score using mean scoring: 1-5 (high score = better outcome)

    Baseline, 6-months, and 12-months

Secondary Outcomes (10)

  • Change in Self-efficacy for Client-centered Communication From Baseline Among Providers

    Baseline, 6-months, and 12-months

  • Change in Empathy Towards Clients From Baseline Among Providers

    Baseline, 6-months, and 12-months

  • Change in the Use of Emotional Regulation and Stress Reduction Techniques From Baseline Among Providers

    Baseline, 6-months, and 12-months

  • Change in Perceived Quality of Communication From HIV Providers From Baseline Among Clients

    Baseline, 6-months, and 12-months

  • Change in Perceived Level of Participatory Decision-making Related to HIV Care From Baseline Among Clients

    Baseline, 6-months, and 12-months

  • +5 more secondary outcomes

Study Arms (4)

Intervention Providers

EXPERIMENTAL

HIV care providers and staff in the intervention arm will receive up to 4 sessions of training. Trained intervention facilitator experienced in health professional trainings will lead the training. The intervention content delivered is aimed to increase HIV providers' knowledge, motivation, skills, and empathy to: 1) equitably deliver ART program guidelines (i.e., quality of care) and 2) provide gender sensitive counseling to address ART patients' gendered barriers to HIV care engagement, increasing patient satisfaction, retention, and ART adherence, and reducing gender disparities in HIV outcomes.

Behavioral: Training for HIV care providers (effect on provider outcomes)

Intervention Clients

EXPERIMENTAL

In the intervention arm clinics, we will enroll a cohort of people living with HIV receiving HIV treatment at the clinics. While they do not receive a direct intervention, we measure change in their outcomes to assess if the provider training intervention has effects on client outcomes.

Behavioral: Training for HIV care providers (effect on provider outcomes)

Control Providers

NO INTERVENTION

The control arm will receive no training. This cohort is of HIV care providers and staff at clinics receiving no intervention.

Control Clients

NO INTERVENTION

The control arm will receive no training. This cohort is of people living with HIV receiving HIV treatment at the control clinics, receiving no intervention.

Interventions

This training program integrates evidence-based strategies to reduce provider bias, adapted to address gender bias in the context of HIV care in Uganda. The content aims to increase providers' knowledge, motivation, skills, and empathy to equitably deliver Ugandan Ministry of Health ART program guidelines to male and female patients (e.g., increasing awareness of HIV gender disparities, increasing empathy/skills to counsel men and women's gendered barriers to care, promoting shared decision-making). The intervention is delivered in a series of group training sessions with HIV providers.

Intervention ClientsIntervention Providers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV care provider at the selected clinics, including HIV medical and clinical officers, nurses, midwives, linkage facilitators, counselors.
  • years of age or older
  • Fluent in English or Luganda
  • Patient Cohort:
  • HIV-infected
  • Enrolled in care at the clinic of recruitment
  • pre-ART (newly diagnosed) or newly initiated on ART (within 3 months-1 year) or struggling with treatment adherence, defined in two ways: (1) most recent viral load results unsuppressed as assessed through clinic records; (2) or self-reported non-adherence as by the Adult AIDS Clinical Trials Group (AACTG) scale 4-day adherence recall questions. This scale has demonstrated good construct validity in Uganda and strong correlations with viral load;
  • years of age or an emancipated minor
  • Fluent in Luganda or English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Luwero Health HCIV

Luwero, Uganda

Location

Namayumba Health HCIV

Namayumba, Uganda

Location

Related Publications (2)

  • Sileo KM, Wanyenze RK, Anecho A, Luttinen RL, Weston K, Mukasa B, Mukama SC, Vermund SH, Dworkin SL, Dovidio JF, Taylor BS, Kershaw TS. Acceptability, feasibility, and factors affecting implementation of a gender-sensitivity training for HIV providers and staff in Uganda: a mixed methods, quasi-experimental controlled pilot trial. BMC Public Health. 2025 May 24;25(1):1925. doi: 10.1186/s12889-025-23008-4.

  • Sileo KM, Wanyenze RK, Anecho A, Luttinen R, Semei C, Mukasa B, Musoke W, Vermund SH, Dworkin SL, Dovidio JF, Taylor BS, Kershaw TS. Protocol for the pilot quasi-experimental controlled trial of a gender-responsive implementation strategy with providers to improve HIV outcomes in Uganda. Pilot Feasibility Stud. 2022 Dec 23;8(1):264. doi: 10.1186/s40814-022-01202-0.

Limitations and Caveats

This study is a pilot trial. Therefore, the results reported are exploratory because they are underpowered. A full-scale efficacy trial is needed to replicate these results.

Results Point of Contact

Title
Katelyn Sileo
Organization
Boston College

Study Officials

  • Katelyn M Sileo, PhD, MPH

    University of Texas at San Antonio

    PRINCIPAL INVESTIGATOR
  • Rhoda K. Wanyenze, MBChB, MPH, PhD

    Makerere School of Pubic Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Clinics will be randomly assigned to intervention or control via coin toss. Two cohorts of participants will be recruited from both the intervention arm and control arm. The total number of participants (N=240) represents the patient cohort, for which change in patient HIV engagement outcomes are the primary outcomes of the study. A second cohort of HIV providers will also be recruited (n\~80-140) depending on the number of HIV providers per clinic, who will provide secondary outcomes related to change in provider knowledge, attitudes, and skills.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2021

First Posted

January 5, 2022

Study Start

December 31, 2021

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

April 25, 2025

Results First Posted

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Quantitative data collected in this trial (baseline, follow-up assessments) will be made available, under the following provisions: (1)The data will be fully de-identified; (2) Access to the data will be made available first to researchers and their students at the two collaborating institutions (within 3 years of study completion): The University of Texas at San Antonio and the Makerere University School of Public Health (MakSPH); 3) 5 years after study completion, data will be made available to those requesting access outside of the collaborating institutions. Qualitative data collected as part of this trial will not be made available, as it is difficult to fully de-identify and to interpret without knowledge of the context.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
3 years after study completion for researchers and students within the collaborating institutions and 5 years after study completion for those outside of the collaborating institutions upon request
Access Criteria
Upon request from the PI

Locations